Travere Therapeutics, Inc. <TVTX.O>: Canaccord Genuity raises target price to $70 from $62
TVTX•Related News
CVS 2027 profit outlook overshadows strong quarter, shares fall
CVS•
Amazon Says Alexa+ Begins Rolling Out In Australia On August 6
AMZN•
JLL arranges permanent financing for Summit Associates’ Edison, N.J., industrial facility
JLL•
U.S. natgas futures edge up on lower output, hot weather
UNG•
Mettler Toledo director Natalia Shuman-Fabbri files initial beneficial ownership statement
MTD•